SCHEMBL21136356

SCHEMBL21136356

CC1(C)CNS(=O)(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22757768 0.74 ALDH1A1 (0.32)
SCHEMBL21101297 0.67
SCHEMBL14413841 0.67
SCHEMBL21136844 0.65
SCHEMBL18063418 0.63
SCHEMBL21911281 0.62
SCHEMBL21276797 0.60 POLB (0.30)
SCHEMBL21136359 0.59
SCHEMBL21910797 0.59
SCHEMBL11692854 0.59 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140647-A1 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2022-06-30 WO disclosed
WO-2020247444-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC, (US) 2020-12-10 WO disclosed
WO-2019113173-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2019-06-13 WO disclosed